Eris Lifesciences Limited (BOM:540596)
India
· Delayed Price · Currency is INR 1,281.10
+29.70 (2.37%)
At close: Feb 19, 2025
Eris Lifesciences Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 27,239 | 19,913 | 16,618 | 13,262 | 11,926 | 10,582 | Upgrade
|
| Revenue Growth (YoY) | 47.99% | 19.83% | 25.31% | 11.20% | 12.71% | 9.41% | Upgrade
|
| Cost of Revenue | 6,782 | 3,964 | 3,613 | 2,640 | 2,419 | 1,753 | Upgrade
|
| Gross Profit | 20,457 | 15,949 | 13,005 | 10,621 | 9,507 | 8,829 | Upgrade
|
| Selling, General & Admin | 5,035 | 4,212 | 3,548 | 2,622 | 2,439 | 2,317 | Upgrade
|
| Other Operating Expenses | 6,263 | 4,963 | 4,070 | 3,108 | 2,762 | 2,791 | Upgrade
|
| Operating Expenses | 14,218 | 11,006 | 8,789 | 6,376 | 5,631 | 5,611 | Upgrade
|
| Operating Income | 6,239 | 4,944 | 4,217 | 4,245 | 3,876 | 3,219 | Upgrade
|
| Interest Expense | -2,100 | -848.01 | -261.68 | -41.46 | -18.02 | -21.62 | Upgrade
|
| Interest & Investment Income | 70.1 | 70.1 | 22.99 | 60.98 | 22.85 | 16.09 | Upgrade
|
| Currency Exchange Gain (Loss) | 18.56 | 18.56 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 73.13 | 55.73 | 17.22 | 15.19 | 14.46 | 51.65 | Upgrade
|
| EBT Excluding Unusual Items | 4,300 | 4,240 | 3,995 | 4,280 | 3,895 | 3,265 | Upgrade
|
| Gain (Loss) on Sale of Investments | 93.76 | 93.76 | 71.32 | 166.09 | 49.77 | 86.22 | Upgrade
|
| Gain (Loss) on Sale of Assets | -21.41 | -21.41 | -20.05 | -42.54 | -0.18 | -37.36 | Upgrade
|
| Other Unusual Items | - | - | - | 18.68 | - | - | Upgrade
|
| Pretax Income | 4,372 | 4,312 | 4,046 | 4,422 | 3,945 | 3,314 | Upgrade
|
| Income Tax Expense | 849.05 | 341.85 | 304.83 | 364.09 | 393.62 | 348.43 | Upgrade
|
| Earnings From Continuing Operations | 3,523 | 3,971 | 3,742 | 4,058 | 3,551 | 2,965 | Upgrade
|
| Minority Interest in Earnings | -229.71 | -50.71 | 79.98 | 3.24 | - | -0.1 | Upgrade
|
| Net Income | 3,294 | 3,920 | 3,822 | 4,061 | 3,551 | 2,965 | Upgrade
|
| Net Income to Common | 3,294 | 3,920 | 3,822 | 4,061 | 3,551 | 2,965 | Upgrade
|
| Net Income Growth | -14.77% | 2.57% | -5.90% | 14.35% | 19.78% | 1.96% | Upgrade
|
| Shares Outstanding (Basic) | 136 | 136 | 136 | 136 | 136 | 137 | Upgrade
|
| Shares Outstanding (Diluted) | 136 | 136 | 136 | 136 | 136 | 137 | Upgrade
|
| Shares Change (YoY) | -0.03% | - | 0.19% | 0.02% | -1.03% | -0.25% | Upgrade
|
| EPS (Basic) | 24.21 | 28.82 | 28.10 | 29.89 | 26.16 | 21.61 | Upgrade
|
| EPS (Diluted) | 24.18 | 28.79 | 28.07 | 29.88 | 26.14 | 21.59 | Upgrade
|
| EPS Growth | -14.75% | 2.57% | -6.06% | 14.31% | 21.07% | 2.18% | Upgrade
|
| Free Cash Flow | - | 3,568 | -5,497 | 2,572 | 3,496 | 1,199 | Upgrade
|
| Free Cash Flow Per Share | - | 26.21 | -40.37 | 18.93 | 25.73 | 8.73 | Upgrade
|
| Dividend Per Share | - | - | 7.350 | 6.010 | 5.500 | 2.870 | Upgrade
|
| Dividend Growth | - | - | 22.30% | 9.27% | 91.64% | - | Upgrade
|
| Gross Margin | 75.10% | 80.10% | 78.26% | 80.09% | 79.71% | 83.44% | Upgrade
|
| Operating Margin | 22.90% | 24.83% | 25.37% | 32.01% | 32.50% | 30.42% | Upgrade
|
| Profit Margin | 12.09% | 19.68% | 23.00% | 30.62% | 29.78% | 28.02% | Upgrade
|
| Free Cash Flow Margin | - | 17.92% | -33.08% | 19.40% | 29.31% | 11.33% | Upgrade
|
| EBITDA | 8,400 | 6,625 | 5,259 | 4,827 | 4,261 | 3,582 | Upgrade
|
| EBITDA Margin | 30.84% | 33.27% | 31.65% | 36.40% | 35.73% | 33.85% | Upgrade
|
| D&A For EBITDA | 2,161 | 1,682 | 1,043 | 582.18 | 384.9 | 363.22 | Upgrade
|
| EBIT | 6,239 | 4,944 | 4,217 | 4,245 | 3,876 | 3,219 | Upgrade
|
| EBIT Margin | 22.90% | 24.83% | 25.37% | 32.01% | 32.50% | 30.42% | Upgrade
|
| Effective Tax Rate | 19.42% | 7.93% | 7.53% | 8.23% | 9.98% | 10.52% | Upgrade
|
| Revenue as Reported | 27,648 | 20,330 | 16,963 | 13,731 | 12,206 | 10,895 | Upgrade
|
| Advertising Expenses | - | 141.98 | 63.85 | 87.47 | 125.05 | 182.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.